Spyre Therapeutics Prices Public Offering of 4.1M Shares at $85.00
Spyre Therapeutics has priced its previously announced underwritten public offering of 4.1 million shares of common stock at a price of $85.00 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.